Diagnostic profile on the IFA 40: HEp-20-10 – an immunofluorescence test for reliable antinuclear antibody screening

References

• Sordet C, Goetz J, Sibilia J. Contribution of autoantibodies to the diagnosis and nosology of inflammatory muscle disease. Joint Bone Spine 2006;73(6):646-54
   PubMed Web of Science ®Google Scholar
• Fritzler MJ. Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes. Autoimmun Rev 2008;7(8):616-20
   PubMed Web of Science ®Google Scholar
• Racanelli V, Prete M, Musaraj G, et al. Autoantibodies to intracellular antigens: generation and pathogenetic role. Autoimmun Rev 2011;10(8):503-8
   PubMed Web of Science ®Google Scholar
• Agmon-Levin N, Damoiseaux J, Kallenberg C, et al. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis 2014;73(1):17-23
   PubMed Web of Science ®Google Scholar
• Kavanaugh A, Tomar R, Reveille J, et al. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med 2000;124(1):71-81
   PubMed Web of Science ®Google Scholar
• American College of Rheumatology. American College of Rheumatology position statement: methodology of testing for antinuclear antibodies. Available from: www.rheumatology.org 2009.1-3
   Google Scholar
• Tozzoli R, Bizzaro N, Tonutti E, et al. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 2002;117(2):316-24
   PubMed Web of Science ®Google Scholar
• Meroni PL, Schur PH. ANA screening: an old test with new recommendations. Ann Rheum Dis 2010;69(8):1420-2
   PubMed Web of Science ®Google Scholar
• Holman HR, Kunkel HG. Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein. Science 1957;126(3265):162-3
   PubMed Web of Science ®Google Scholar
• Holborow EJ, Weir DM, Johnson GD. A serum factor in lupus erythematosus with affinity for tissue nuclei. Br Med J 1957;2(5047):732-4
   PubMed Web of Science ®Google Scholar
• Friou GJ. Antinuclear antibodies: diagnostic significance and methods. Arthritis Rheum 1967;10(2):151-9
   PubMed Web of Science ®Google Scholar
• Shovman O, Gilburd B, Barzilai O, et al. Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies. Ann N Y Acad Sci 2005;1050:380-8
   PubMed Web of Science ®Google Scholar
• Tonuttia E, Bassetti D, Piazza A, et al. Diagnostic accuracy of ELISA methods as an alternative screening test to indirect immunofluorescence for the detection of antinuclear antibodies. Evaluation of five commercial kits. Autoimmunity 2004;37(2):171-6
   PubMed Web of Science ®Google Scholar
• Tozzoli R, Bonaguri C, Melegari A, et al. Current state of diagnostic technologies in the autoimmunology laboratory. Clin Chem Lab Med 2013;51(1):129-38
   PubMed Web of Science ®Google Scholar
• Fritzler MJ, Fritzler ML. The emergence of multiplexed technologies as diagnostic platforms in systemic autoimmune diseases. Curr Med Chem 2006;13(21):2503-12
   PubMed Web of Science ®Google Scholar
• Hanly JG, Su L, Farewell V, Fritzler MJ. Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus. J Immunol Methods 2010;358(1-2):75-80
   PubMed Web of Science ®Google Scholar
• Bonilla E, Francis L, Allam F, et al. Immunofluorescence microscopy is superior to fluorescent beads for detection of antinuclear antibody reactivity in systemic lupus erythematosus patients. Clin Immunol 2007;124(1):18-21
   PubMed Web of Science ®Google Scholar
• Op de BK, Vermeersch P, Verschueren P, et al. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay. Autoimmun Rev 2011;10(12):801-8
   PubMed Web of Science ®Google Scholar
• Moore AE, Sabachewsky L, Toolan HW. Culture characteristics of four permanent lines of human cancer cells. Cancer Res 1955;15(9):598-602
   PubMed Web of Science ®Google Scholar
• Solomon DH, Kavanaugh AJ, Schur PH. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 2002;47(4):434-44
   PubMed Web of Science ®Google Scholar
• Wiik AS, Hoier-Madsen M, Forslid J, et al. Antinuclear antibodies: a contemporary nomenclature using HEp-2 cells. J Autoimmun 2010;35(3):276-90
   PubMed Web of Science ®Google Scholar
• Sack U, Conrad K, Csernok E, et al. Autoantibody detection using indirect immunofluorescence on HEp-2 cells. Ann N Y Acad Sci 2009;1173:166-73
   PubMed Web of Science ®Google Scholar
• Dellavance A, Gallindo C, Soares MG, et al. Redefining the Scl-70 indirect immunofluorescence pattern: autoantibodies to DNA topoisomerase I yield a specific compound immunofluorescence pattern. Rheumatology (Oxford) 2009;48(6):632-7
   PubMed Web of Science ®Google Scholar
• Frodlund M, Dahlstrom O, Kastbom A, et al. Associations between antinuclear antibody staining patterns and clinical features of systemic lupus erythematosus: analysis of a regional Swedish register. BMJ Open 2013;3(10):e003608
   Web of Science ®Google Scholar
• Dahle C, Skogh T, Aberg AK, et al. Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy. J Autoimmun 2004;22(3):241-8
   PubMed Web of Science ®Google Scholar
• Almeida Gonzalez D, Cabrera de Leon A, del Cristo Rodriguez Perez C, et al. Efficiency of different strategies to detect autoantibodies to extractable nuclear antigens. J Immunol Methods 2010;360(1-2):89-95
   PubMed Web of Science ®Google Scholar
• Dellavance A, Junior AG, Nuccitelli B, et al. Third Brazilian Consensus for autoantibodies screening in HEp-2 cells (ANA). Recommendations for standardization of autoantibodies screening trial in HEp-2 cells, quality control and clinical associations. Rev Bras Reumatol 2009;49(2):89-109
   Google Scholar
• Mahler M, Fritzler MJ. The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseases. Clin Dev Immunol 2012;2012:494356
   PubMedGoogle Scholar
• Almeida Brito dF, Elòi Santos SM, Aparecida Ferreira G, et al. Detection of anti-nuclear antibodies by indirect immunofl uorescence on HEp-2 cells: setting the appropriate screening dilution for the diagnosis of autoimmune rheumatic diseases. Revista Brasileira De Reumatologia 2013;54(1):13-20
   Google Scholar
• Satoh M, Chan EK, Ho LA, et al. Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum 2012;64(7):2319-27
   PubMed Web of Science ®Google Scholar
• Mariz HA, Sato EI, Barbosa SH, et al. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases. Arthritis Rheum 2011;63(1):191-200
   PubMed Web of Science ®Google Scholar
• Tan EM, Feltkamp TEW, Smolen JS, et al. Range of antinuclear antibodies in healthy individuals. Arthritis Rheumatism 1997;40(9):1601-11
   PubMedGoogle Scholar
• Eriksson C, Kokkonen H, Johansson M, et al. Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden. Arthritis Res Ther 2011;13(1):R30
   PubMed Web of Science ®Google Scholar
• Li Q-Z, Karp DR, Quan J, et al. Risk factors for ANA positivity in healthy persons. Arthritis Res Ther 2011;13:2:R38
   Web of Science ®Google Scholar
• Satoh M, Chan EK, Sobel ES, et al. Clinical implication of autoantibodies in patients with systemic rheumatic diseases. Expert Rev Clin Immunol 2007;3(5):721-38
   PubMedGoogle Scholar
• Fritzler MJ. The antinuclear antibody test: last or lasting gasp? Arthritis Rheum 2011;63(1):19-22
   PubMedGoogle Scholar
• Mahler M, Hanly JG, Fritzler MJ. Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases. Autoimmun Rev 2012;11(9):642-5
   PubMed Web of Science ®Google Scholar
• Hanke K, Bruckner CS, Dahnrich C, et al. Antibodies against PM/Scl-75 and PM/Scl-100 are independent markers for different subsets of systemic sclerosis patients. Arthritis Res Ther 2009;11(1):R22
   Web of Science ®Google Scholar
• Vermeersch P, Bossuyt X. Prevalence and clinical significance of rare antinuclear antibody patterns. Autoimmun Rev 2013;12(10):998-1003
   PubMed Web of Science ®Google Scholar
• Euroimmun. Available from: www.euroimmun.com
   Google Scholar
• Autoantibody Standardization Committee. Available from: www.AutoAB.org
   Google Scholar
• Copple SS, Giles SR, Jaskowski TD, et al. Screening for IgG antinuclear autoantibodies by HEp-2 indirect fluorescent antibody assays and the need for standardization. Am J Clin Pathol 2012;137(5):825-30
   PubMed Web of Science ®Google Scholar
• Meroni PL, Biggioggero M, Pierangeli SS, et al. Standardization of autoantibody testing: a paradigm for serology in rheumatic diseases. Nat Rev Rheumatol 2014;10(1):35-43
   PubMed Web of Science ®Google Scholar
• Conrad K, Roggenbuck D, Reinhold D, Sack U. Autoantibody diagnostics in clinical practice. Autoimmun Rev 2012;11(3):207-11
   PubMed Web of Science ®Google Scholar
• Tozzoli R, Antico A, Porcelli B, Bassetti D. Automation in indirect immunofluorescence testing: a new step in the evolution of the autoimmunology laboratory. Autoimmun Highlights 2012;3(2):59-65
   PubMedGoogle Scholar
• Hiemann R, Buttner T, Krieger T, et al. Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells. Autoimmun Rev 2009;9(1):17-22
   PubMed Web of Science ®Google Scholar
• Voigt J, Krause C, Rohwader E, et al. Automated indirect immunofluorescence evaluation of antinuclear autoantibodies on HEp-2 cells. Clin Dev Immunol 2012;2012:651058
   PubMedGoogle Scholar
• Egerer K, Roggenbuck D, Hiemann R, et al. Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence tests. Arthritis Res Ther 2010;12(2):R40
   PubMed Web of Science ®Google Scholar
• Kivity S, Gilburd B, Gmon-Levin N, et al. A novel automated indirect immunofluorescence autoantibody evaluation. Clin Rheumatol 2012;31(3):503-9
   PubMed Web of Science ®Google Scholar
• Melegari A, Bonaguri C, Russo A, et al. A comparative study on the reliability of an automated system for the evaluation of cell-based indirect immunofluorescence. Autoimmun Rev 2012;11(10):713-16
   PubMed Web of Science ®Google Scholar
• Copple SS, Jaskowski TD, Giles R, Hill HR. Interpretation of ANA indirect immunofluorescence test outside the darkroom using NOVA view compared to manual microscopy. J Immunol Res 2014;2014:149316
   PubMed Web of Science ®Google Scholar
• Bonroy C, Verfaillie C, Smith V, et al. Automated indirect immunofluorescence antinuclear antibody analysis is a standardized alternative for visual microscope interpretation. Clin Chem Lab Med 2013;51(9):1771-9
   PubMed Web of Science ®Google Scholar
• Bossuyt X, Cooreman S, De BH, et al. Detection of antinuclear antibodies by automated indirect immunofluorescence analysis. Clin Chim Acta 2013;415:101-6
   PubMed Web of Science ®Google Scholar
• Bizzaro N, Antico A, Platzgummer S, et al. Automated antinuclear immunofluorescence antibody screening: a comparative study of six computer-aided diagnostic systems. Autoimmun Rev 2014;13(3):292-8
   PubMed Web of Science ®Google Scholar
• Krause C, Ens K, Fechner K, et al. EUROPattern-Suite technology for computer-aided immunofluorescence microscopy in autoantibody diagnostics. Lupus 2014; In press
   Web of Science ®Google Scholar